About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [1,791 citations: 101–200 of 1,563 articles]

Articles published in International Journal of Alzheimer’s Disease have been cited 1,791 times. The following is a list of the 1,563 articles that have cited the articles published in International Journal of Alzheimer’s Disease.

  • Fanlin Meng, Enyu Dai, Xuexin Yu, Yan Zhang, Xiaowen Chen, Xinyi Liu, Shuyuan Wang, and Lihua Wang, “Constructing and characterizing a bioactive small molecule and microRNA ass ociation network for Alzheimer's disease,” Journal of The Royal Society Interface, vol. 11, no. 92, 2014. View at Publisher · View at Google Scholar
  • Michael Steinman, Kristine Ensrud, Teresa A. Hillier, and Kristine Yaffe, “Long-term Cognitive and Functional Effects of Potentially Inappropriate Med ications in Older Women,” Journals of Gerontology Series A-Biological Sciences and Medical Sciences, vol. 69, no. 4, pp. 423–429, 2014. View at Publisher · View at Google Scholar
  • Kirsty Olsen, John-Paul Taylor, and Alan Thomas, “Mild cognitive impairment: Safe to drive?,” Maturitas, 2014. View at Publisher · View at Google Scholar
  • Dai Mizuno, Hironari Koyama, Keiko Konoha, Susumu Ohkawara, and Yutaka Sadakane, “Disruption of zinc homeostasis and the pathogenesis of senile dementia,” Metallomics, vol. 6, no. 2, pp. 209–219, 2014. View at Publisher · View at Google Scholar
  • Fabian M. Nensa, Martin H. D. Neumann, Andreas Schroetter, Andre Przyborski, Thomas Mastalski, Sergej Susdalzew, Christina Loosse, Stefan Helling, Fouzi El Magraoui, Ralf Erdmann, Helmut E. Meyer, Julian Uszkoreit, Martin Eisenacher, Jaehong Suh, Suzanne Y. Guenette, Nelli Roehner, Donat Koegel, Carsten Theiss, and Katrin Marcus, “Amyloid Beta A4 Precursor Protein-binding Family B Member 1 (FE65) Interact omics Revealed Synaptic Vesicle Glycoprotein 2A (SV2A) and Sarcoplasmic/End oplasmic Reticulum Calcium ATPase 2 (SERCA2) as New Binding Proteins in the Human Brain,” Molecular & Cellular Proteomics, vol. 13, no. 2, pp. 475–488, 2014. View at Publisher · View at Google Scholar
  • A. Carpentieri, A. Marchionatti, V. Areco, A. Perez, and V. Centeno, “Antioxidant and antiapoptotic properties of melatonin restore intestinal ca lcium absorption altered by menadione,” Molecular and Cellular Biochemistry, vol. 387, no. 1-2, pp. 197–205, 2014. View at Publisher · View at Google Scholar
  • Aleksandar Krstic, Thomas Schwarzl, Desmond G. Higgins, and Walter Kolch, “GSK3 Inhibitors Regulate MYCN mRNA Levels and Reduce Neuroblastoma Cell Via bility through Multiple Mechanisms, Including p53 and Wnt Signaling,” Molecular Cancer Therapeutics, vol. 13, no. 2, pp. 454–467, 2014. View at Publisher · View at Google Scholar
  • W K Jo, A C K Law, and S K Chung, “The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders,” Molecular Psychiatry, vol. 19, no. 2, pp. 159–167, 2014. View at Publisher · View at Google Scholar
  • Günter U. Höglinger, Hans-Jürgen Huppertz, Stefan Wagenpfeil, María V Andrés, Vincente Belloch, Teresa León, and Teodoro del Ser, “Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial,” Movement Disorders, 2014. View at Publisher · View at Google Scholar
  • Ryuichi Sakai, and Geoffrey T. Swanson, “Recent progress in neuroactive marine natural products,” Natural Product Reports, vol. 31, no. 2, pp. 273, 2014. View at Publisher · View at Google Scholar
  • Xin Zhou, Chun Yang, Yufeng Liu, Peng Li, Huiying Yang, Jingxing Dai, and Rongmei Qu, “Lipid rafts participate in aberrant degradative autophagic-lysosomal pathwa y of amyloid-beta peptide in Alzheimer's disease,” Neural Regeneration Research, vol. 9, no. 1, pp. 92–100, 2014. View at Publisher · View at Google Scholar
  • Jennifer S. Yokoyama, Shana M. Katzman, Michael A. Nalls, Anne B. Newman, Tamara B. Harris, Matteo Cesari, Todd M. Manini, Nicholas J. Schork, Steven R. Cummings, Yongmei Liu, and Kristine Yaffe, “Mitochondrial DNA sequence associations with dementia and amyloid-beta in e lderly African Americans,” Neurobiology of Aging, vol. 35, no. 2, 2014. View at Publisher · View at Google Scholar
  • Eun-Joo Kim, Jay C. Kwon, Kee Hyung Park, Kyung-Won Park, Jae-Hong Lee, Seong Hye Choi, Jee H. Jeong, Byeong C. Kim, Soo Jin Yoon, Young Chul Yoon, SangYun Kim, Key-Chung Park, Byung-Ok Choi, Duk L. Na, and Seung Hyun Kim, “Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean pat ients with frontotemporal dementia,” Neurobiology of Aging, vol. 35, no. 5, 2014. View at Publisher · View at Google Scholar
  • Meng-Shan Tan, Jin-Tai Yu, Teng Jiang, Xi-Chen Zhu, Hua-Shi Guan, and Lan Tan, “Genetic variation in BIN1 gene and Alzheimer’s disease risk in Han Chinese,” Neurobiology of Aging, 2014. View at Publisher · View at Google Scholar
  • Noemí Fabelo, Virginia Martín, Raquel Marín, Dolores Moreno, Isidre Ferrer, and Mario Díaz, “Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer disease and facilitates APP/BACE1 interactions,” Neurobiology of Aging, 2014. View at Publisher · View at Google Scholar
  • H. Lison, M. F. K. Happel, F. Schneider, K. Baldauf, S. Kerbstat, B. Seelbinder, J. Schneeberg, M. Zappe, J. Goldschmidt, E. Budinger, U. H. Schroeder, F. W. Ohl, S. Schilling, H. -U. Demuth, H. Scheich, and K. G. Reymann, “Disrupted cross-laminar cortical processing in beta amyloid pathology prece des cell death,” Neurobiology of Disease, vol. 63, pp. 62–73, 2014. View at Publisher · View at Google Scholar
  • Lance A. Johnson, Reid H.J. Olsen, Louise S. Merkens, Andrea DeBarber, Robert D. Steiner, Patrick M. Sullivan, Nobuyo Maeda, and Jacob Raber, “Apolipoprotein E – Low Density Lipoprotein Receptor Interaction Affects Spatial Memory Retention and Brain ApoE Levels in an Isoform-Dependent Manner,” Neurobiology of Disease, 2014. View at Publisher · View at Google Scholar
  • Stefania Trazzi, Claudia Fuchs, Marianna De Franceschi, Valentina Maria Mitrugno, Renata Bartesaghi, and Elisabetta Ciani, “APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome,” Neurobiology of Disease, 2014. View at Publisher · View at Google Scholar
  • Jens Pahnke, Oliver Langer, and Markus Krohn, “Alzheimer’s and ABC transporters - new opportunities for diagnostics and treatment,” Neurobiology of Disease, 2014. View at Publisher · View at Google Scholar
  • Xiaoping Wang, Yongjie Luo, and Hongbin Sun, “Chronic administration of D-galactose enhances astrocytic activities in rat cerebral medulla,” Neurochemical Journal, vol. 8, no. 1, pp. 33–37, 2014. View at Publisher · View at Google Scholar
  • Guo-Long Mo, Ying Li, Rong-hui Du, De-Zai Dai, Xiao-Dong Cong, and Yin Dai, “Isoproterenol Induced Stressful Reactions in the Brain Are Characterized by Inflammation due to Activation of NADPH Oxidase and ER Stress: Attenuated by Apocynin, Rehmannia Complex and Triterpene Acids,” Neurochemical Research, 2014. View at Publisher · View at Google Scholar
  • Johannes Lehmann, Janine Mett, Valerie C. Zimmer, Sven Groesgen, Christoph P. Stahlmann, Benjamin Hundsdoerfer, Viola J. Haupenthal, Tatjana L. Rothhaar, Christian Herr, Robert Bals, Heike S. Grimm, and Tobias Hartmann, “Impact of Vitamin D on Amyloid Precursor Protein Processing and Amyloid-bet a Peptide Degradation in Alzheimer's Disease,” Neurodegenerative Diseases, vol. 13, no. 2-3, pp. 75–81, 2014. View at Publisher · View at Google Scholar
  • Peter Kochunov, Neda Jahanshad, Emma Sprooten, Thomas E. Nichols, René C. Mandl, Laura Almasy, Tom Booth, Rachel M. Brouwer, Joanne E. Curran, Greig I. de Zubicaray, Rali Dimitrova, Ravi Duggirala, Peter T. Fox, L. Elliot Hong, Bennett A. Landman, Hervé Lemaitre, Lorna Lopez, Nicholas G. Martin, Katie L. McMahon, Braxton D. Mitchell, Rene L. Olvera, Charles P. Peterson, John M. Starr, Jessika E. Sussmann, Arthur W. Toga, Joanna M. Wardlaw, Margaret J. Wright, Susan N. Wright, Mark E. Bastin, Andrew M. McIntosh, Dorret I. Boomsma, René S. Kahn, Anouk den Braber, Eco J.C. de Geus, Ian J. Deary, Hilleke E. Hulshoff Pol, Douglas E. Williamson, John Blangero, Dennis van ’t Ent, Paul M. Thompson, and David C. Glahn, “Multi-site study of additive genetic effects on fractional anisotropy of cerebral white matter: Comparing meta and mega analytical approaches for data pooling,” NeuroImage, 2014. View at Publisher · View at Google Scholar
  • Luis R. Peraza, Marcus Kaiser, Michael Firbank, Sara Graziadio, Laura Bonanni, Marco Onofrj, Sean J. Colloby, Andrew Blamire, John O'Brien, and John-Paul Taylor, “fMRI resting state networks and their association with cognitive fluctuations in dementia with Lewy bodies,” NeuroImage: Clinical, vol. 4, pp. 558–565, 2014. View at Publisher · View at Google Scholar
  • Rossana Bonsi, Elio Scarpini, and Daniela Galimberti, “Innate Immune System and Inflammation in Alzheimer's Disease: From Pathogen esis to Treatment,” Neuroimmunomodulation, vol. 21, no. 2-3, pp. 79–87, 2014. View at Publisher · View at Google Scholar
  • John A. Bertelson, and Bela Ajtai, “Neuroimaging of Dementia,” Neurologic Clinics, vol. 32, no. 1, pp. 59–93, 2014. View at Publisher · View at Google Scholar
  • Guiyou Liu, Haiyang Wang, Jiafeng Liu, Jingbo Li, Hali Li, Guoda Ma, Yongshuai Jiang, Zugen Chen, and Bin Zhao, “The CLU Gene rs11136000 Variant is Significantly Associated with Alzheimer' s Disease in Caucasian and Asian Populations,” Neuromolecular Medicine, vol. 16, no. 1, pp. 52–60, 2014. View at Publisher · View at Google Scholar
  • A. Saul, J. Kacza, J. Grosche, S. Goldhammer, D. Michalski, and O. Wirths, “Immunolesion-induced loss of cholinergic projection neurones promotes beta- amyloidosis and tau hyperphosphorylation in the hippocampus of triple-trans genic mice,” Neuropathology and Applied Neurobiology, vol. 40, no. 2, pp. 106–120, 2014. View at Publisher · View at Google Scholar
  • Susana Revilla, Cristina Suñol, Yoelvis García-Mesa, Lydia Giménez-Llort, Coral Sanfeliu, and Rosa Cristòfol, “Physical Exercise Improves Synaptic Dysfunction and Recovers the Loss of Survival Factors in 3xTg-AD Mouse Brain,” Neuropharmacology, 2014. View at Publisher · View at Google Scholar
  • P. Martinez, A. Corrales, N. Fandos, S. Garcia, D. Insua, M. Montanes, V. Perez-Grijalba, N. Rueda, V. Vidal, C. Martinez-Cue, P. Pesini, and M. Sarasa, “CHANGES IN THE BRAIN AND PLASMA Ab PEPTIDE LEVELS WITH AGE AND ITS RELATION SHIP WITH COGNITIVE IMPAIRMENT IN THE APPswe/PS1dE9 MOUSE MODEL OF ALZHEIME R'S DISEASE,” Neuroscience, vol. 263, pp. 269–279, 2014. View at Publisher · View at Google Scholar
  • Cindy Beharry, Leah S. Cohen, Jing Di, Kawsar Ibrahim, Susan Briffa-Mirabella, and Alejandra del C. Alonso, “Tau-induced neurodegeneration: mechanisms and targets,” Neuroscience Bulletin, vol. 30, no. 2, pp. 346–358, 2014. View at Publisher · View at Google Scholar
  • Irina Petrushina, Hayk Davtyan, Armine Hovakimyan, Tommy Saing, Arpine Davtyan, David H. Cribbs, and Michael G. Agadjanyan, “Immunogenicity of epitope vaccines targeting different B cell antigenic det erminants of human alpha-synuclein: Feasibility study,” Neuroscience Letters, vol. 560, pp. 86–91, 2014. View at Publisher · View at Google Scholar
  • Sandeep Kumar Singh, Ruchi Gaur, Akhil Kumar, Roshan Fatima, Lallan Mishra, and Saripella Srikrishna, “The Flavonoid Derivative 2-(4′ Benzyloxyphenyl)-3-hydroxy-chromen-4-one Protects Against Aβ42-Induced Neurodegeneration in Transgenic Drosophila: Insights from In Silico and In Vivo Studies,” Neurotoxicity Research, 2014. View at Publisher · View at Google Scholar
  • Vijay Kumar, and Kiran Dip Gill, “Oxidative Stress and Mitochondrial Dysfunction in Aluminium Neurotoxicity and Its Amelioration: A Review,” NeuroToxicology, 2014. View at Publisher · View at Google Scholar
  • Erin L. Cole, Xia Shao, Phillip Sherman, Carole Quesada, Maria V. Fawaz, Timothy J. Desmond, and Peter J.H. Scott, “Synthesis and evaluation of [11C]PyrATP-1, a novel radiotracer for PET imaging of glycogen synthase kinase-3β (GSK-3β),” Nuclear Medicine and Biology, 2014. View at Publisher · View at Google Scholar
  • Nathalie Arnal, Lina Dominici, and Maria J. T. de Tacconi, “Copper-induced alterations in rat brain depends on route of overload and ba sal copper levels,” Nutrition, vol. 30, no. 1, pp. 96–106, 2014. View at Publisher · View at Google Scholar
  • Sergio Montes, Susana Rivera-Mancia, Araceli Diaz-Ruiz, Luis Tristan-Lopez, and Camilo Rios, “Copper and Copper Proteins in Parkinson’s Disease,” Oxidative Medicine and Cellular Longevity, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Lan He, Nurcan Ueceyler, Heidrun H. Kraemer, Maria Nandini Colaco, Bao Lu, and Frank Birklein, “Methylprednisolone prevents nerve injury-induced hyperalgesia in neprilysin knockout mice,” Pain, vol. 155, no. 3, pp. 574–580, 2014. View at Publisher · View at Google Scholar
  • Francisco M. C. Sampaio, and Carlos Sequeira, “Nurses' Knowledge and Practices in Cases of Acute and Chronic Confusion: A Questionnaire Survey,” Perspectives in Psychiatric Care, 2014. View at Publisher · View at Google Scholar
  • Jessica Askamp, and Michel J. A. M. van Putten, “Computer-Assisted Interpretation of the EEG Background Pattern: A Clinical Evaluation,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Maya Mathew, “In Vitro Screening for Anti-Cholinesterase and Antioxidant Activity of Meth anolic Extracts of Ayurvedic Medicinal Plants Used for Cognitive Disorders,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Norio Sasaoka, Megumi Sakamoto, Shoko Kanemori, Michiru Kan, Chihiro Tsukano, and Yoshiji Takemoto, “Long-Term Oral Administration of Hop Flower Extracts Mitigates Alzheimer Ph enotypes in Mice,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Herve Maurin, Seon-Ah Chong, Igor Kraev, Heather Davies, Anna Kremer, Claire Marie Seymour, Benoit Lechat, Tomasz Jaworski, Peter Borghgraef, Herman Devijver, Geert Callewaert, and Michael G. Stewart, “Early Structural and Functional Defects in Synapses and Myelinated Axons in Stratum Lacunosum Moleculare in Two Preclinical Models for Tauopathy,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Cheri L. Geist, Heather A. Kenna, Tonita E. Wroolie, Katherine E. Williams, and Daniel H. S. Silverman, “Prospective Randomized Trial to Assess Effects of Continuing Hormone Therap y on Cerebral Function in Postmenopausal Women at Risk for Dementia,” Plos One, vol. 9, no. 3, 2014. View at Publisher · View at Google Scholar
  • Arcangela Iuso, Ody C. M. Sibon, Matteo Gorza, Katharina Heim, Cristina Organisti, and Thomas Meitinger, “Impairment of Drosophila Orthologs of the Human Orphan Protein C19orf12 Ind uces Bang Sensitivity and Neurodegeneration,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Laura Bica, Jeffrey R. Liddell, Paul S. Donnelly, Clare Duncan, Aphrodite Caragounis, Irene Volitakis, Brett M. Paterson, Roberto Cappai, Alexandra Grubman, James Camakaris, and Peter J. Crouch, “Neuroprotective Copper Bis(thiosemicarbazonato) Complexes Promote Neurite E longation,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Elise Aasebo, Jill Anette Opsahl, Yngvild Bjorlykke, Kjell-Morten Myhr, and Ann Cathrine Kroksveen, “Effects of Blood Contamination and the Rostro-Caudal Gradient on the Human Cerebrospinal Fluid Proteome,” Plos One, vol. 9, no. 3, 2014. View at Publisher · View at Google Scholar
  • Kristoffer Brannstrom, Malin Lindhagen-Persson, Anna L. Gharibyan, Irina Iakovleva, Monika Vestling, Mikael E. Sellin, Thomas Brannstrom, Ludmilla Morozova-Roche, and Lars Forsgren, “A Generic Method for Design of Oligomer-Specific Antibodies,” Plos One, vol. 9, no. 3, 2014. View at Publisher · View at Google Scholar
  • Saeid Ghavami, Shahla Shojaeid, Behzad Yeganeh, Sudharsana R. Ande, Jaganmohan R. Jangamreddy, Maryam Mehrpour, Jonas Christoffersson, Wiem Chaabane, Adel Rezaei Moghadam, Hessam H. Kashani, Mohammad Hashemi, and Ali A. Owji, “Autophagy and apoptosis dysfunction in neurodegenerative disorders,” Progress in Neurobiology, vol. 112, pp. 24–49, 2014. View at Publisher · View at Google Scholar
  • Ivo F. Scheiber, Julian F.B. Mercer, and Ralf Dringen, “Metabolism and functions of copper in brain,” Progress in Neurobiology, 2014. View at Publisher · View at Google Scholar
  • Jan Pláteník, Zdeněk Fišar, Richard Buchal, Roman Jirák, Eva Kitzlerová, Martina Zvěřová, and Jiří Raboch, “GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 50, pp. 83–93, 2014. View at Publisher · View at Google Scholar
  • Tetsu Tomita, Norio Sugawara, Ayako Kaneda, Noriyuki Okubo, Kaori Iwane, Ippei Takahashi, and Sunao Kaneko, “Sex-specific effects of subjective memory complaints with respect to cognit ive impairment or depressive symptoms,” Psychiatry and Clinical Neurosciences, vol. 68, no. 3, pp. 176–181, 2014. View at Publisher · View at Google Scholar
  • Mengchao Cui, Ruikun Tang, Jinming Zhang, Xiaojun Zhang, Zijing Li, and Hongmei Jia, “Carbon-11 labeled stilbene derivatives from natural products for the imagin g of A beta plaques in the brain,” Radiochimica Acta, vol. 102, no. 1, pp. 185–192, 2014. View at Publisher · View at Google Scholar
  • Shougang Wei, Wenli Shi, Man Li, and Qian Gao, “ Calorie Restriction Down-Regulates Expression of the Iron Regulatory Hormone Hepcidin in Normal and d -Galactose–Induced Aging Mouse Brain ,” Rejuvenation Research, vol. 17, no. 1, pp. 19–26, 2014. View at Publisher · View at Google Scholar
  • N.B. Bolshette, K.K. Thakur, A.P. Bidkar, C. Trandafir, P. Kumar, and R. Gogoi, “Protein folding and misfolding in the neurodegenerative disorders: A review,” Revue Neurologique, 2014. View at Publisher · View at Google Scholar
  • Chengjie Xiong, Mateusz S. Jasielec, Randall J. Bateman, Alison M. Goate, Tammie L. S. Benzinger, Bernardino Ghetti, Ralph N. Martins, Colin L. Masters, Richard Mayeux, John M. Ringman, Martin N. Rossor, Stephen Salloway, Peter R. Schofield, Reisa A. Sperling, Daniel Marcus, Nigel J. Cairns, Virginia D. Buckles, Jack H. Ladenson, John C. Morris, and David M. Holtzman, “Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Dis ease,” Science Translational Medicine, vol. 6, no. 226, 2014. View at Publisher · View at Google Scholar
  • Alice Breining, B. Lavallart, S. Pin, C. Leon, S. Moulias, P. Arwidson, F. Beck, C. Berr, and M. Verny, “Perception of Alzheimer’s disease in the French population,” The journal of nutrition, health & aging, 2014. View at Publisher · View at Google Scholar
  • Tobias Pobandt, and Volker Knecht, “ Free Energy of Lipid Bilayer Defects Affected by Alzheimer’s Disease-Associated Amyloid-β 42 Monomers ,” The Journal of Physical Chemistry B, pp. 140320111739008, 2014. View at Publisher · View at Google Scholar
  • Daniel R. George, Heather L. Stuckey, and Megan M. Whitehead, “An arts-based intervention at a nursing home to improve medical students' attitudes toward persons with dementia,” Academic Medicine, vol. 88, no. 6, pp. 837–842, 2013. View at Publisher · View at Google Scholar
  • Thomas Hauser, Peter Schoenknecht, Philipp A. Thomann, Lars Gerigk, Johannes Schroeder, Romy Henze, Alexander Radbruch, and Marco Essig, “Regional Cerebral Perfusion Alterations in Patients with Mild Cognitive Imp airment and Alzheimer Disease Using Dynamic Susceptibility Contrast MRI,” Academic Radiology, vol. 20, no. 6, pp. 705–711, 2013. View at Publisher · View at Google Scholar
  • Orkid Coskuner, Olivia Wise-Scira, George Perry, and Taizo Kitahara, “The Structures of the E22Δ Mutant-Type Amyloid-β Alloforms and the Impact of E22Δ Mutation on the Structures of the Wild-Type Amyloid-β Alloforms,” ACS Chemical Neuroscience, vol. 4, no. 2, pp. 310–320, 2013. View at Publisher · View at Google Scholar
  • J.A. Morales-García, A. Martínez, A. Pérez-Castillo, C. Susín, S. Alonso-Gil, D.I. Pérez, V. Palomo, C. Pérez, S. Conde, A. Santos, and C. Gil, “Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson disease,” ACS Chemical Neuroscience, vol. 4, no. 2, pp. 350–360, 2013. View at Publisher · View at Google Scholar
  • Pei Huang, Fulin Lian, Yi Wen, Chenyun Guo, and Donghai Lin, “Prion protein oligomer and its neurotoxicity,” Acta Biochimica et Biophysica Sinica, vol. 45, no. 6, pp. 442–451, 2013. View at Publisher · View at Google Scholar
  • Jianhui Liu, Yonglan Zhang, Xiaohong Deng, and Fei Yin, “Geniposide decreases the level of Aβ1-42 in the hippocampus of streptozotocin-induced diabetic rats,” Acta Biochimica et Biophysica Sinica, vol. 45, no. 9, pp. 787–791, 2013. View at Publisher · View at Google Scholar
  • Henrik Zetterberg, Kelly Del Tredici, and Kaj Blennow, “Intraneuronal tau aggregation precedes diffuse plaque deposition, but amylo id-beta changes occur before increases of tau in cerebrospinal fluid,” Acta Neuropathologica, vol. 126, no. 5, pp. 631–641, 2013. View at Publisher · View at Google Scholar
  • Patty C. Kandalepas, Katherine R. Sadleir, William A. Eimer, Jie Zhao, Daniel A. Nicholson, and Robert Vassar, “The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques,” Acta Neuropathologica, 2013. View at Publisher · View at Google Scholar
  • Peter T. Nelson, Charles D. Smith, Erin L. Abner, Bernard J. Wilfred, Wang-Xia Wang, Janna H. Neltner, Michael Baker, David W. Fardo, Richard J. Kryscio, Stephen W. Scheff, Gregory A. Jicha, Kurt A. Jellinger, Linda J. Eldik, and Frederick A. Schmitt, “Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease,” Acta Neuropathologica, 2013. View at Publisher · View at Google Scholar
  • Clifford R. Jack, Jorge R. Barrio, and Vladimir Kepe, “Cerebral amyloid PET imaging in Alzheimer’s disease,” Acta Neuropathologica, 2013. View at Publisher · View at Google Scholar
  • Rachel M. Bailey, Jason P. Covy, Heather L. Melrose, Linda Rousseau, Ruth Watkinson, Joshua Knight, Sarah Miles, Matthew J. Farrer, Dennis W. Dickson, Benoit I. Giasson, and Jada Lewis, “LRRK2 phosphorylates novel tau epitopes and promotes tauopathy,” Acta Neuropathologica, 2013. View at Publisher · View at Google Scholar
  • Raymond Chuen-Chung Chang, Yuen-Shan Ho, Shun Wong, Stephen M. Gentleman, and Ho-Keung Ng, “Neuropathology of cigarette smoking,” Acta Neuropathologica, 2013. View at Publisher · View at Google Scholar
  • Yansong Li, Mikulas Chavko, Jessica L Slack, Bin Liu, Richard M McCarron, James D Ross, and Jurandir Lucca, “Protective effects of decay-accelerating factor on blast-induced neurotrauma in rats,” Acta Neuropathologica Communications, vol. 1, no. 1, pp. 52, 2013. View at Publisher · View at Google Scholar
  • Jing Sun, Yin-quan Fang, Hong Ren, Tao Chen, Jing-jing Guo, Jun Yan, Shu Song, Lu-yong Zhang, and Hong Liao, “WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra fol lowing permanent focal cerebral ischemia in rats,” Acta Pharmacologica Sinica, vol. 34, no. 1, pp. 119–128, 2013. View at Publisher · View at Google Scholar
  • Z. Flachbartova, “Mortalin - a multipotent chaperone regulating cellular processes ranging fr om viral infection to neurodegeneration,” Acta Virologica, vol. 57, no. 1, pp. 2–15, 2013. View at Publisher · View at Google Scholar
  • Annalisa Relini, Nadia Marano, and Alessandra Gliozzi, “Probing the interplay between amyloidogenic proteins and membranes using lipid monolayers and bilayers,” Advances in Colloid and Interface Science, 2013. View at Publisher · View at Google Scholar
  • Syeda Huma Naqvi, and Bart Sheehan, “Screening for dementia in general hospital inpatients: a systematic review and meta-analysis of available instruments,” Age and Ageing, vol. 42, no. 6, pp. 689–695, 2013. View at Publisher · View at Google Scholar
  • Diane Slats, Jurgen A.H.R. Claassen, Marcel M. Verbeek, and Sebastiaan Overeem, “Reciprocal interactions between sleep, circadian rhythms and Alzheimer's disease: Focus on the role of hypocretin and melatonin,” Ageing Research Reviews, vol. 12, no. 1, pp. 188–200, 2013. View at Publisher · View at Google Scholar
  • Jennifer Reijnders, Caroline van Heugten, and Martin van Boxtel, “Cognitive interventions in healthy older adults and people with mild cognitive impairment: A systematic review,” Ageing Research Reviews, vol. 12, no. 1, pp. 263–275, 2013. View at Publisher · View at Google Scholar
  • Colin Cook, Paul G. Shiels, Stephen D. Lawn, and Clare Gilbert, “The eye as a model of ageing in translational research - Molecular, epigene tic and clinical aspects,” Ageing Research Reviews, vol. 12, no. 2, pp. 490–508, 2013. View at Publisher · View at Google Scholar
  • Stephanie L. Leal, and Michael A. Yassa, “Perturbations of neural circuitry in aging, mild cognitive impairment, and Alzheimer's disease,” Ageing Research Reviews, 2013. View at Publisher · View at Google Scholar
  • Johanna L. Crimins, Amy Pooler, Manuela Polydoro, Jennifer I. Luebke, and Tara L. Spires-Jones, “The intersection of amyloid beta and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease,” Ageing Research Reviews, 2013. View at Publisher · View at Google Scholar
  • Xiao-rui Cheng, Wen-xia Zhou, and Yong-xiang Zhang, “The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model,” Ageing Research Reviews, 2013. View at Publisher · View at Google Scholar
  • Anita Stargardt, Judith Gillis, Willem Kamphuis, Anne Wiemhoefer, Lieneke Kooijman, Marcel Raspe, Willemien Benckhuijsen, Jan W. Drijfhout, Elly M. Hol, and Eric Reits, “Reduced amyloid- degradation in early Alzheimer's disease but not in the AP PswePS1dE9 and 3xTg-AD mouse models,” Aging Cell, vol. 12, no. 3, pp. 499–507, 2013. View at Publisher · View at Google Scholar
  • Christopher N. Sozda, Michael Marsiske, and William M. Perlstein, “Within-session practice eliminates age differences in cognitive control,” Aging Neuropsychology and Cognition, vol. 20, no. 5, pp. 522–531, 2013. View at Publisher · View at Google Scholar
  • Petra E. Spies, Jurgen A. H. R. Claassen, Petronella G. M. Peer, Marinus A. Blankenstein, Charlotte E. Teunissen, Philip Scheltens, Wiesje M. van der Flier, Marcel G. M. Olde Rikkert, and Marcel M. Verbeek, “A prediction model to calculate probability of Alzheimer's disease using ce rebrospinal fluid biomarkers,” Alzheimers & Dementia, vol. 9, no. 3, pp. 262–268, 2013. View at Publisher · View at Google Scholar
  • Maria C. Carrillo, Kaj Blennow, Holly Soares, Piotr Lewczuk, Niklas Mattsson, Pankaj Oberoi, Robert Umek, Manu Vandijck, Salvatore Salamone, Tobias Bittner, Leslie M. Shaw, Diane Stephenson, Lisa Bain, and Henrik Zetterberg, “Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: An update from the Alzheimer's Association Global Biomarkers Cons ortium,” Alzheimers & Dementia, vol. 9, no. 2, pp. 137–140, 2013. View at Publisher · View at Google Scholar
  • Wesley Jongbloed, Maartje I. Kester, Wiesje M. van der Flier, Robert Veerhuis, Philip Scheltens, Marinus A. Blankenstein, and Charlotte E. Teunissen, “Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer’s disease study,” Alzheimer's & Dementia, vol. 9, no. 3, pp. 276–283, 2013. View at Publisher · View at Google Scholar
  • Anna H. Noel-Storr, Leon Flicker, Craig W. Ritchie, Giang Huong Nguyen, Tarun Gupta, Phillip Wood, Josephine Walton, Meera Desai, Danielle Fraser Solomon, Emma Molena, Rosemary Worrall, Anja Hayen, Prateek Choudhary, Emma Ladds, Krista L. Lanctôt, Frans R. Verhey, Jenny M. McCleery, Gillian E. Mead, Linda Clare, Mario Fioravanti, Chris Hyde, Sue Marcus, and Rupert McShane, “Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia,” Alzheimer's & Dementia, vol. 9, no. 3, pp. e96–e105, 2013. View at Publisher · View at Google Scholar
  • Maria C. Carrillo, Christopher C. Rowe, Cassandra Szoeke, Colin L. Masters, David Ames, Tim O’Meara, S. Lance Macaulay, Andrew Milner, Kathryn A. Ellis, Paul Maruff, Stephanie R. Rainey-Smith, Ralph N. Martins, Lisa J. Bain, and Richard J. Head, “Research and standardization in Alzheimer's trials: Reaching international consensus,” Alzheimer's & Dementia, vol. 9, no. 2, pp. 160–168, 2013. View at Publisher · View at Google Scholar
  • Keith A. Johnson, Satoshi Minoshima, Nicolaas I. Bohnen, Kevin J. Donohoe, Norman L. Foster, Peter Herscovitch, Jason H. Karlawish, Christopher C. Rowe, Maria C. Carrillo, Dean M. Hartley, Saima Hedrick, Virginia Pappas, and William H. Thies, “Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association,” Alzheimer's & Dementia, vol. 9, no. 1, pp. E1–E16, 2013. View at Publisher · View at Google Scholar
  • Niklas Mattsson, Ulf Andreasson, Staffan Persson, Maria C. Carrillo, Steven Collins, Sonia Chalbot, Neal Cutler, Diane Dufour-Rainfray, Anne M. Fagan, Niels H.H. Heegaard, Ging-Yuek Robin Hsiung, Bradley Hyman, Khalid Iqbal, D. Richard Lachno, Alberto Lleó, Piotr Lewczuk, José L. Molinuevo, Piero Parchi, Axel Regeniter, Robert Rissman, Hanna Rosenmann, Giuseppe Sancesario, Johannes Schröder, Leslie M. Shaw, Charlotte E. Teunissen, John Q. Trojanowski, Hugo Vanderstichele, Manu Vandijck, Marcel M. Verbeek, Henrik Zetterberg, Kaj Blennow, and Stephan A. Käser, “CSF biomarker variability in the Alzheimer's Association quality control program,” Alzheimer's & Dementia, vol. 9, no. 3, pp. 251–261, 2013. View at Publisher · View at Google Scholar
  • Kim Henriksen, Sid E. O’Bryant, Harald Hampel, John Q. Trojanowski, Thomas J. Montine, Andreas Jeromin, Kaj Blennow, Anders Lönneborg, Tony Wyss-Coray, Holly Soares, Chantal Bazenet, Magnus Sjögren, William Hu, Simon Lovestone, Morten A. Karsdal, and Michael W. Weiner, “The future of blood-based biomarkers for Alzheimer's disease,” Alzheimer's & Dementia, 2013. View at Publisher · View at Google Scholar
  • Swetha Vijayaraghavan, Walter Maetzler, Matthias Reimold, Christina Unger Lithner, Inga Liepelt-Scarfone, Daniela Berg, and Taher Darreh-Shori, “High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia,” Alzheimer's & Dementia, 2013. View at Publisher · View at Google Scholar
  • Claire F. Evans, Hayk Davtyan, Irina Petrushina, Armine Hovakimyan, Arpine Davtyan, Drew Hannaman, David H. Cribbs, Michael G. Agadjanyan, and Anahit Ghochikyan, “Epitope-based DNA vaccine for Alzheimer's disease: Translational study in macaques,” Alzheimer's & Dementia, 2013. View at Publisher · View at Google Scholar
  • Sylvain Lehmann, Susanna Schraen, Isabelle Quadrio, Claire Paquet, Stéphanie Bombois, Constance Delaby, Aline Dorey, Julien Dumurgier, Christophe Hirtz, Pierre Krolak-Salmon, Jean-Louis Laplanche, Olivier Moreaud, Katell Peoc'h, Olivier Rouaud, Bernard Sablonnière, Eric Thouvenot, Jacques Touchon, Olivier Vercruysse, Jacques Hugon, Audrey Gabelle, Florence Pasquier, and Armand Perret-Liaudet, “Impact of harmonization of collection tubes on Alzheimer's disease diagnosis,” Alzheimer's & Dementia, 2013. View at Publisher · View at Google Scholar
  • Robert J. Blendon, and John M. Benson, “Would you want to know? Public attitudes on early diagnostic testing for Al zheimer's disease,” Alzheimers Research & Therapy, vol. 5, no. 5, 2013. View at Publisher · View at Google Scholar
  • Amy M. Pooler, Manuela Polydoro, Susanne Wegmann, Samantha B. Nicholls, and Tara L. Spires-Jones, “Propagation of tau pathology in Alzheimer's disease: identification of nove l therapeutic targets,” Alzheimers Research & Therapy, vol. 5, no. 5, 2013. View at Publisher · View at Google Scholar
  • Jon B Toledo, Leslie M Shaw, and John Q Trojanowski, “Plasma amyloid beta measurements - A desired but elusive Alzheimer's disease biomarker,” Alzheimer's Research and Therapy, vol. 5, no. 2, 2013. View at Publisher · View at Google Scholar
  • Lorraine Fuhrmann Clark, and Thomas Kodadek, “Advances in blood-based protein biomarkers for Alzheimer's disease,” Alzheimer's Research and Therapy, vol. 5, no. 3, 2013. View at Publisher · View at Google Scholar
  • Robyn M. Loureiro, Brian S. Bronk, Barbara Tate, Jo Ann Dumin, Timothy D. McKee, Wesley F. Austin, Nathan O. Fuller, Jed L. Hubbs, Ruichao Shen, Jeff Jonker, and Jeff Ives, “Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models,” Alzheimer's Research and Therapy, vol. 5, no. 2, 2013. View at Publisher · View at Google Scholar
  • Alba Sánchez, José C. Millán-Calenti, Laura Lorenzo-López, and Ana Maseda, “Multisensory stimulation for people with dementia: A review of the literature,” American Journal of Alzheimer's Disease and other Dementias, vol. 28, no. 1, pp. 7–14, 2013. View at Publisher · View at Google Scholar